Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers big health, digestiv...
Shanghai and Shenzhen A Shrs Midday Down 0.4% to 2.3%; Banks and Pharma Stocks Buck Trend
HAINAN HAIYAO: Class I new drugs lead the way in dual lines, and the success of Phase II clinical trials highlights growth potential
The A-share Hainan Free Trade Zone concept fluctuated strongly, with SUNDIRO HOLDING hitting the daily limit, HNHD previously locked, and Caesar Travel, Honz, HNSS, HAINAN HAIYAO, and HAIMA AUTO following suit
November 26th Midday Review: The ChiNext Index rose 2.76% in half a day, with CPO and pharmaceutical stocks collectively strengthening
In half a day, the main funds increased their positions in the media sector and sold off the non-ferrous metals sector
Hainan Haiyao's subsidiary has obtained the drug registration approval for Fumaric Acid Vorinostat Tablets